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A B S T R A C T
The purpose of this study was to develop and validate a high-performance liquid chromatography with a diode-
array detector (HPLC-DAD) method for the determination of short-chain fatty acids (SCFAs) such as: acetic,
propionic, butyric, valeric and isovaleric acids in meconium. Additionally, the proposed analytical procedure
was used to determine SCFAs in meconium obtained from 17 neonates. All determined organic acids in meco-
nium samples were separated with good resolution. The HPLC system was characterized by high precision (the
coefficient of variance ≤ 2.5%), high determination coefficients of calibration curves (R2>0.997) and low limits
of detection (LOD) and quantification (LOQ). For all investigated organic acids, LOD ranged from 0.01 to
0.80 mmol/ kg and LOQ values ranged between 0.04 and 2.64 mmol/ kg. Recovery of the HPLC assay for
individual analytes comprised the range of 90± 2 - 106± 2%. Concentrations of acids in meconium collected
from healthy children varied in wide ranges (CV within the range 0.79–2.47%) and no regularity was found in
the molar ratios of the individual acids. The validation parameters obtained in this study, made the HPLC-DAD
method reliable and useful tool for the determination of short-chain fatty acids in meconium samples.
1. Introduction
Short-chain fatty acids (SCFAs) are mainly monocarboxylic, satu-
rated, aliphatic acids containing from 1 to 6 carbon atoms per molecule
[1]. These include acetic, propionic, butyric, valeric, succinic or caproic
acid [2]. SCFAs are the main and final products of a fermentation
process carried out by anaerobic bacteria living in the human large
intestine [3]. The basic substrates in the fermentation process are
polysaccharides that have not been digested by intestinal enzymes be-
fore. They include non-starch polysaccharides (NSPs), dietary fiber and
resistant starch, prebiotics (e.g. inulin), oligofructose or sugar alcohols
(sorbitol, mannitol) [2, 4]. The acetic, propionic and butyric acids to-
gether account for 95% of the content of all short chain fatty acids
produced in the human colon [5], while they remain in a relatively
constant molar ratio of 60:20:18, 60:25:10 or 60:25:15 [1, 6, 7]. In
much smaller amounts, also other short-chain acids are formed, such as
formic, succinic and capric acid [1].
Short-chain fatty acids play a key role in the proper functioning of
the human digestive system [8]. SCAFs are involved in the regulation of
intestinal pH, facilitate the absorption of certain minerals (calcium,
iron, magnesium) in the distal part of the colon, and promote the de-
velopment of beneficial bacterial microflora, which, on a competitive
basis, inhibits the growth of pathogenic bacteria [8–10].
The properties of butyric acid are particularly well described. This
compound exhibits trophic effects associated with the acceleration of
healing and regeneration within the intestinal epithelium, and has local
anti-inflammatory, immunoregulatory and antineoplastic properties,
although the latter one have so far been confirmed only by in vitro tests
[4, 11–14].
Short-chain fatty acids show not only local effects on the colon
epithelium, but after passage from the intestines to the bloodstream,
they can also bind to fatty acid receptors - GPR41, GPR43, OLFR78,
located in peripheral tissues [2]. In this way, SCFAs are able to regulate
some physiological processes occurring in the human body. These
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include effects on the immune system response to pathogens, modula-
tion of blood pressure or regulation of leptin level secretion, a hormone
that is involved in the regulation of fatty resources in the body, blood
glucose levels and in reducing appetite [2, 15–17].
The production of short-chain fatty acids depends on many factors,
including quantitative and qualitative composition of intestinal micro-
biota and the availability of substrates for the bacterial fermentation
process [18]. It seems, that the proper composition of the intestinal
microflora has a significant impact on the proper functioning of the
human body.
Colonization of the gastrointestinal tract by intestinal bacteria be-
gins at birth, and the first two years of child life are of key importance
in the process of the final formation of the intestinal microflora.
Colonization of intestine is time dependent with enterobacteriaceae and
streptococci predominating during the first 1–3 days after the birth,
when concentrations of these organisms peak at 1011 cfu/g in feces
[19]. Certain factors, including the type of delivery (natural or cesarian
delivery), feeding - breastfeeding or formula milk, the need to admin-
ister drugs, especially antibiotics, the use of probiotics, as well as hy-
giene and the environment life, may have a significant impact not only
on the composition of the bacterial consortium, but also on whole
health of an individual [20].
The analysis of the data carried out by Sevelsted et al. from the
Danish national registers covering the years 1977–2012 (data from
about 2 million children) showed that children born via cesarian sec-
tion are significantly more exposed to diseases such as: asthma, juvenile
arthritis, leukemia, systemic connective tissue disorders, immune defi-
ciencies and inflammatory bowel disease [21]. This may be related to
the reduction of the number of beneficial bacteria of the genus Bifido-
bacterium and Lactobacillus, as well as the generally lower level of
biodiversity of bacterial microflora in children born by cesarian de-
livery compared to children who were naturally delivered [22]. Me-
conium is the very first stool of a newborn baby and is normally passed
for the first 1–5 h after birth [23]. It begins to form in fetus gastro-
intestinal tract between 12 and 16 weeks of pregnancy and accumulates
until birth [24]. Meconium, unlike later feces has usually very dark
green color and it is almost odorless [25]. It has a complex matrix
composed of amniotic fluid residue, cellular debris like flaked cells of
the skin and of digestive tract, gastrointestinal secretions and enzymes,
lanugo, fatty material from the vernix caseosa, cholesterol and pre-
cursors of sterols, bile acids and salts, mucopolysaccharide blood group
substances [26], proteins [27], sugars [28] as well as trace elements
[29]. So far meconium has been used mainly in toxicological research.
It has been successfully employed in monitoring fetal exposure to drugs
and their metabolites (e.g. cocaine, opiates, alcohol, cannabinoids) [23,
27, 30], persistent organic pollutants [31], pesticides [32] inorganic
contamination (e.g. heavy metals) [33] and antibiotic [34]. There has
been scarce investigations devoted to the determination of short-chain
organic acids in meconium samples [35, 36]. SCFAs in meconium were
mainly determined using the gas chromatography method developed by
Zijlstra et al. [37] with modification introduced by Höverstad et al.
[38]. Nevertheless, this methodology required purification by vacuum
distillation which is time-consuming. Similarly, other approaches de-
veloped for determination of SCFAs in stools samples require removing
of proteins [39] or further derivatization [40].
Rasmussen et al. [35] found that the molar ratio of acetic, propionic
and butyric acids in meconium is 89:5:5, but one should note that ac-
cording to mean and standard deviations of the concentrations of in-
vestigated acids reported therein, their variability should be considered
as high. In case of particular individuals the molar ratio of analytes
might be significantly different.
In this study, the validation of the simple analytical procedure using
acidic extraction followed by the HPLC analysis for determination of
short-chain organic acids in meconium was performed. Moreover, de-
scribed procedure was applied to evaluate concentration of organic
acids in meconium samples collected from 17 neonates.
The analysis of meconium samples, particularly the determination
of SCFAs, can broaden the knowledge about the impact of food com-
ponents in maternal diet on fetal metabolism. This is especially im-
portant because of contradictory information in the available literature
about the profile and quantity of SCFAs in meconium [35, 36, 39].
Additionally, the analysis of SCFAs in meconium could be of great value
also in establishing SCFAs as new and potentially significant indicators
of different disturbances in gastrointestinal tract such as bacterial me-
conium infection or propionic acidosis. Thus the results of the study
may lead to developing new therapeutic strategies.
2. Materials and methods
2.1. Chemicals
The deionized water of 18 M Ω cm was obtained from Milli Ro & Q
water purification system (Merck-Millipore, Billerica, MA, USA).
Organic acids and other reagents were of analytical standard grade or
gradient grade. Acetonitrile (ACN), acetic acid, propionic acid, butyric
acid, adipic acid, valeric acid, isovaleric acid and perchloric acid (70%)
were purchased from Sigma-Aldrich (Steinheim, Germany), while 98%
diethylamine and 85% orthophosphoric acid were purchased from
Merck (Darmstadt, Germany).
2.2. Sample collection
Meconium samples were collected from 17 healthy children born
either via cesarian section (n = 8) or through vaginal delivery (n = 9)
in the University Hospital in Kraków. The meconium samples were
gathered immediately after the first new-born's defecation into sterile
plastic vessels. The collected samples were then instantly put into the
freezer and stored at -20 °C, to avoid changes in the SCFAs concentra-
tion. The study design was approved by the Bioethics Committee of the
Jagiellonian University Medical College.
2.3. Meconium sample preparation
Sample preparation procedure was based on our previous experi-
ments [41]. Before the extraction process, samples were dried in a
forced-air drying oven at +40 °C. Next, the samples were ground and
mixed manually (mini handheld homogenizer) prior to be aliquoted.
Meconium aliquots, of average amount of 500 mg of dry weight each,
were transferred into 10 mL plastic tubes. Then the content of each
vessel was mixed with 2.5 mL of perchloric acid (0.15 M) and the tubes
tightly twisted. The extraction procedure was divided into two steps.
During the first step the samples were exposed to ultrasound energy at
+40 °C, (Ultrasonic Bath, Power 400 W, ULTRON U-503, Poland) for
80 min. During the second step the samples were shaken for 60 min at
room temperature. After the extraction, the extracts were centrifuged
for 15 min at 5000 rpm at room temperature. The supernatant was then
filtered with mixed cellulose esters membrane (MCE, 0.45 µm, Nantong
FilterBio Membrane Co., China). The sample extracts were stored frozen
at −20 °C until analysis.
2.4. HPLC instrument
The concentrations of organic acids were determined using a high-
performance liquid chromatography system (Prominence, Shimadzu,
Kyoto, Japan) consisting of a Shimadzu LC-20AD pump, liquid chro-
matography SIL-20A autosampler and SPD-M20A diode-array detector.
The analytes were separated on a Synergi 4 u Hydro-RP 80A C18
column (250 × 4.6 mm, 4 µm) at 35 °C. The HPLC system operated at
flow rate 1 mL/min in gradient mode by mixing (A) ACN with (B)
phosphoric buffer (pH 2.36), prepared by adding 1.4 mL 85% phos-
phoric acid and 1 mL diethylamine to a volumetric flask (1 L) and di-
luting to volume with deionized water to the mark. Both solutions were
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additionally degassed by ultrasonication before use. The gradient pro-
gram: 0 min A:5%, 6 min A:20%, 12 min A:30%, 16 min A:30%, 25 min
A:40%, 28 min A:80%, 32 min A:80% and 35 min A:5% was used. After
each run the column was further equilibrated for 3 min with A:5%.
Such gradient program provide satisfactory resolution for all com-
pounds of interest except acetic acid, and moreover the repeatability of
retention times was below 1%. In this latter case a significant inter-
ference caused by matrix components was found, thus the determina-
tion of acetic acid was performed subsequently using mobile phase B for
the isocratic elution. Each sample was analyzed two-fold (in three re-
petitions) using two different mobile phases. Before measurement,
samples were appropriately diluted (5–25 fold) in deionized water
(18 MΩcm) and filtered through a nylon 0.22-µm syringe filter (13 mm,
Labe Ltd. Filter-Bio, Nantong, China). Samples were degassed in an
ultrasonic bath.
2.5. Method validation
Validation was performed by evaluation of the following parameters
of the method: linearity range, limits of detection and quantification,
precision (CV) and accuracy calculated as the recovery of the HPLC
assay. The peaks were identified basing on the retention time compared
with ones collected within the analysis of standard mixture and by
spiking samples with SCFAs standards to confirm the identification. For
quantification of organic acids, the external calibration curve was cal-
culated by the analysis of calibrators at following concentration levels:
3.125, 6.25, 12.5, 25, 50, 100 and 200 mg/L for acetic acid, propionic
acid, butyric acid, valeric acid and isovaleric acid. In addition, adipic
acid was considered as non-characteristic of stool samples to test the
selectivity of the method.
The linearity range was estimated by plotting peak area corre-
sponding to each organic acid against the analyte concentration and
then using the least squares method for calculation of respective re-
gression coefficients and the determination coefficient (R2). According
to the validation protocol, the determination coefficient had to meet the
criterion of R2 > 0.995.
The precision of the method was expressed and the coefficient of
variance and it was evaluated by successive analysis of the sample so-
lutions, using six independent repetitions, at the same working day. The
validation criterion for precision was±2.5%.
The recovery study was limited to evaluation of the HPLC assay, as
the amount of meconium sample collected from newborns was highly
limited. It was determined by spiking the sample extracts with known
concentrations of analytes (+50% of an analyte amount determined in
an initial measurement of the same but non-spiked sample).
The limit of detection (LOD) and limit of quantification (LOQ) for
each organic acid were calculated by taking into account the residual
standard deviation (SD) of the analytical signal and slope of the cali-
bration curve (s), according to the formulas: LOD = 3.3 SD/s,
LOQ = 10 SD/s, respectively.
2.6. Statistical analysis
Descriptive statistics were calculated for all fatty acids. Comparisons
between concentrations of different fatty acids were performed using
Kruskal-Wallis test with Dunn's post hoc test to reveal the differences
between the paired acids. Differences with p<0.05 were considered as
statistically significant. The statistical analyses were carried out using
packages STATISTICA v. 12 (Statsoft, Tulsa, OK, USA) and GraphPad
Prism v. 3.02 (GraphPad Software, San Diego, USA).
3. Results and discussion
The method for determination of short-chain fatty acids in meco-
nium was developed and subsequently validated. The chromatograms
of the HPLC analysis of a standard mixture and the example of meco-
nium sample are presented in Fig. 1. The proposed HPLC method al-
lowed the separation of five short-chain acids in meconium samples
with satisfactory resolution. The possible interference between the
isovaleric peak (Fig. 1, peak f) and the adjacent peak was found neg-
ligible for quantitative and qualitative analysis. The peak purity eva-
luation revealed that the influence of the interference is low and stable
and it does not affect the precision and accuracy of the method if peaks
are splitted in the valley point and the base line is marked using the
drop perpendicular methodology.
One should note, that due to analytical interferences acetic acid
cannot be determined using gradient method, so in this case a different
methodology was used (see HPLC instrument section) and results are
demonstrated in Fig. 2. The validation parameters are presented in
Table 1. Calibration curves for all analytes were linear in the con-
centration range of 3.125 - 200 mg/L with high determination coeffi-
cients of calibration curves (R2 > 0.997). The HPLC system was char-
acterized by high sensitivity and low limits of detection and
quantification, particularly the lowest LOD and LOQ values were ob-
tained for propionic acid, which were 0.01 and 0.04 mmol/kg respec-
tively. The highest LOD and LOQ parameters were found for acetic acid
and they were 0.80 and 2.64 mmol/kg, respectively.
Valerio et al. [42] evaluated the parameters of the method for
Fig. 1. Chromatographic separation (gradient elution) of organic acids in exemplary sample of meconium (chromatrogram B) and a standard mixture of six acids
(chromatogram A). Signal assignments: a - acetic acid (a*- visible interference) , b - propionic acid, c - adipic acid, d - butiric acid, e - isovaleric acid, f – valeric acid.
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determining the organic acids in adult fecal samples using the HPLC
system with 3-channel UV detector. The limits of quantification for
propionic and butyric acids were found to be higher (1.72 and
0.85 mmol/kg, respectively) and for acetic, valeric and isovaleric acids
lower (0.55, 0.48 and 0.09 mmol/kg, respectively) than those reported
in the present study. However, it should be noted that the established
LOQs proved to be sufficient to determine the last three acids in all
samples of the meconium in our study.
Recovery of the HPLC analysis for individual compounds comprised
the range of 90 ± 2 -106 ± 2% (n = 3) which indicates that the
developed HPLC separation is not affected by interferences. However,
only the sample extracts were spiked with appropriate concentration of
analytes and such approach confined the insight into the effect of
sample preparation on recovery, but the limited amount (enough only
for a single extraction) and number of available meconium samples
forced such protocol. The results were characterized by high precision
as CV determined for each acid did not exceed 2.5%. The performance
parameters of SCFAs determination in meconium material using the
HPLC method are not available in literature. It should be stressed that
reference analytical procedures for SCFAs determination in stool sam-
ples were actually developed and used to determine these analytes in
human feces and not particularly in meconium [35, 36]. It is well
known that human fecal matter varies according to the diet and health
status. Therefore, the chemical composition of feces of neonates (me-
conium) and of adults might be extremely different, except for water
content as it water constitutes always 75–80% of the stools. In con-
sequence, one may expect e.g. different interferences in case of the
analysis of these two materials.
Despite some disadvantages, gas chromatography is still the most
commonly used analytical method to determine meconium SCFAs.
Rasmussen et al. [35] and Midtvedt et al. [36] measured short-chain
fatty acids in meconium samples after acidification (with H2SO4) and
vacuum distillation steps according to the method of Zijlstra et al. [37]
with modification by Höverstad et al. [38]. Recoveries for the acids in
the whole analytical procedure (including sample pretreatment) ranges
from 90–109% , thus it was similar to those received in this work.
However, the pretreatment procedure [37, 38] is time consuming
and therefore it is (i) associated with the risk of loss of volatile acids,
and (ii) difficult to use for large number of samples (e.g. in routine
analysis). Underwood et al. [40] determined also short-chain fatty acid
in stool samples from infants at age of 4 weeks. The preparation of the
sample for measurement consisted of several main stages, such as:
acidification (with 0.15 mmol/L H2SO4), derivatisation (with acidic 2-
nitrophenylhydrazine hydrochloride), extraction with hexane to re-
move long-chain fatty acids hydrazides and with diethylether to sepa-
rate the SCFA derivatives, and finally evaporation of the solvent over-
night. Obtained extracts were analyzed using reverse-phase HPLC-UV
method. In turn, Szylit et al. [39] used mercuric chloride to remove
proteins and phosphotungstic acid solution was added and settle
overnight to deproteinize supernatants. SFCA separation was con-
ducted by means of GC-FID. In both of the cited procedures, no method
parameter was shown. In our work, the sample preparation for mea-
surement was based on the previously developed method with some
modification [41] consisting of three short steps: acidification with
0.15 M HClO4, ultrasound digestion (80 min. at 35 °C) and shaking
(60 min.). In comparison to the previous procedure, the duration of
individual steps has been lengthened. Furthermore, the developed
protocol is more efficient and less time consuming than those presented
in the past. Indeed, the time required to accomplish such two steps
analysis (as in the developed protocol, which involves two separate
chromatographic runs), is longer, but still acceptable if compared to GC
protocols, well established and widely used in fatty acids analysis, e.g.
using the FFAP column (free fatty acid phase column) without deriva-
tization of analytes (ca. 20 min) [43]. Nevertheless, according to some
reports on FFAP columns, on the one hand – they offer really fast
analyses and share certain characteristics of PGE columns, but on the
other – they are also less stable and robust and have lower temperature
limits than most polysiloxanes columns [44], which requires derivati-
zation lasting from several minutes to 48 h [45].
The whole procedure for preparing the sample for the measurement
is relatively quick and easy, however, it is associated with the risk of
Fig. 2. Chromatographic analysis (isocratic elution) of exemplary sample of meconium (chromatrogram B) and a standard solution of acetic acid (chromatogram A);
visible signal of acetic acid.
Table 1











acetic 0.9985 0.80 2.64 1.80 106 ± 2
propionic 0.9999 0.01 0.04 1.75 101 ± 2
adipic 0.9971 0.65 1.95 2.47 105 ± 1
butyric 1.000 0.24 0.72 1.41 101 ± 1
isovaleric 0.9998 0.30 0.90 0.79 90 ± 2
valeric 0.9976 0.59 1.76 0.97 99 ± 1
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impurities, that can cause overloading of the system and column con-
tamination. As a consequence, it may affect the quality of the chro-
matographic column and worse the separation of sample analytes. In
order to prevent this, a pre-column was used and after each batch of
analyzed samples the column was rinsed for a long time with water and
acetonitrile (20:80). During the study, no significant changes in re-
tention time nor peak shapes were observed.
3.1. Application of the method
Meconium samples were collected from 17 healthy children born
either via cesarean or vaginal. None of the samples showed the presence
of adipic acid. The determined values of concentrations of all acids were
expressed in mmol per kg of dry matter (Table 2.). In case of 10 sam-
ples, the concentration of propionic acid was below LOD. In order to
include all observations in calculations of descriptive statistics (and
thus into Median value in Table 2) the <LOD results were substituted
with LOD/√2, according to the method described in [46]. It was noticed
that the concentrations of acids in meconium varied in wide ranges,
and, unlike in adult human feces, there was no clear trend in the case of
molar ratios of individual acid concentrations. Each stool sample had a
different ratio of short-chain organic acids. Fig. 3. shows the
Table 2
Concentration of organic acids in meconium [mmol/kg].
Sample Concentration of organic acid in meconium [mmol/kg] Molar ratio
Acetic acid Propionic acid Butyric acid Isovaleric acid Valeric acid
1CS 49.83 ± 0.99 23.84 ± 1.37 9.14 ± 0.15 2.50 ± 0.08 3.64 ± 0.04 56:27:10:3:4
2CS 76.67 ± 1.68 10.77 ± 0.41 157.25 ± 6.13 9.96 ± 0.28 42.84 ± 2.17 26:4:53:3:14
3CS 58.17 ± 1.25 <LOD 17.73 ± 0.27 1.25 ± 0.00 4.10 ± 0.06 -
4CS 13.83 ± 0.31 5.81 ± 0.18 15.46 ± 018 2.49 ± 0.06 4.25 ± 0.37 33:14:37:6:10
5CS 23.17 ± 0.23 66.26 ± 3.40 195.81 ± 3.51 37.26 ± 2.49 69.01 ± 2.10 6:17:50:9:18
6CS 22.50 ± 0.45 3.65 ± 0.04 6.19 ± 0.33 1.85 ± 0.02 2.99 ± 1.16 60:10:17:5:8
7CS 92.33 ± 1.71 <LOD 61.54 ± 0.93 11.04 ± 0.54 18.64 ± 1.13 -
8CS 124.17 ± 2.26 <LOD 83.28 ± 0.50 35.58 ± 1.14 57.68 ± 0.16 -
1VD 24.5 ± 0.35 28.57 ± 0.11 1.31 ± 0.04 2.40 ± 0.07 7.76 ± 0.04 38:44:2:4:12
2VD 56.42 ± 1.2 26.49 ± 3.56 133.34 ± 3.35 26.04 ± 0.53 41.81 ± 3.31 20:9:47:9:15
3VD 33.92 ± 0.55 4.75 ± 0.24 170.25 ± 1.21 11.22 ± 0.13 32.79 ± 0.67 13:2:67:5:13
4VD 36.75 ± 0.48 <LOD 67.62 ± 0.45 6.06 ± 0.06 28.48 ± 0.42 -
5VD 47.94 ± 0.92 <LOD 25.02 ± 0.80 5.38 ± 0.04 11.83 ± 0.24 -
6VD 40.17 ± 0.79 <LOD 14.40 ± 0.22 7.53 ± 0.09 10.37 ± 0.06 -
7VD 21.04 ± 31 <LOD 230.24 ± 8.05 4.98 ± 0.18 98.22 ± 0.17 -
8VD 40.00 ± 0.77 <LOD 14.57 ± 0.09 1.96 ± 0.18 3.42 ± 0.20 -
9VD 35.34 ± 0.91 121.23 ± 7.70 110.52 ± 0.62 28.47 ± 0.72 24.21 ± 1.06 11:38:35:9:7
Median* 40.00ab 3.65ac 61.55cd 6.06bd 18.64
CS - Meconium samples from children born via cesarian section.
VD - Meconium samples from children born via natural vaginal delivery.
a. b. c. d - the same letters indicate significant differences in median values (p < 0.05).
⁎ In case of propionic acid median was calculated taking into account substitution of <LOD results with LOD/√2 = 0.0007.
Fig. 3. The median concentrations of SCFAs in meconium from children born either via cesarean section (CS) or vaginal delivery (VD).
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comparison between the median concentrations for individual acids in
the meconium samples of infants born via cesarian section (CS) or va-
ginal delivery (VD). Due to the small number of samples within one
group, statistical analysis was not performed. Acetic acid (median:
40.00 mmol/kg) and butyric acid (median: 61.55 mmol/kg) were the
most abundant SCFAs found in meconium samples. The median con-
centrations of these SCFAs were significantly higher than determined
propionic (median: 3.65 mmol/kg) and isovaleric acids (6.06 mmol/kg)
(p<0.05). The differences between the median values of acetic acid and
butyric acid and of propionic and isovaleric acids were not statistically
significant. The mean concentration value determined for valeric acid
and other acids did not differ significantly.
Midtvedt et al. [36] studied the changes in short-chain fatty acid
concentrations in feces from 29 healthy children during the first two
years of their life. In the meconium of all children, acetic acid was
determined at mean value of 5.2 mmol/kg. Only in case of four in-
vestigated children meconium samples propionic acid (mean value:
0.1 mmol/kg) and n-butyric acid (mean value: 0.5 mmol/kg) were
quantitatively estimated. Other investigated SCFAs, such valeric and i-
valeric acids as well as and i-butyric and n-caproic acids were not found
in meconium samples.
In our study we determined acetic acid, butyric acid, valeric acid
and i-valeric acid in every sample, and propionic acid in 10 samples.
Considering that the water content in meconium is about 80%, the
obtained median concentrations of acetic, n-butyric and propionic acids
(40.00 mmol/kg, 61.55 mmol/kg and 3.65 mmol/kg, respectively) in
the tested material were higher than those obtained by Midtvedt et al.
In turn, Rasmussen et al. [35] determined the concentrations of acetic,
propionic and butyric acid in meconium from 13 newborns. The acetic
acid was the most abundant one, while the concentration of propionic
and butyric acids was much lower. However, due to the ambiguous
interpretation of units in which the concentration of analytes (mmol/L)
was expressed the results obtained by Rasmussen et al. cannot be di-
rectly compared with results presented in this work. Moreover, the
variability of the SCFAs concentrations in meconium samples, reported
by Rasmussen et al. [35], suggests that the actual SCFAs molar ratio
may vary between children as it was also found in our study (see
Table 2).
It should also be noted that the meconium itself is not a homo-
geneous sample - its formation begins around the 20th week of fetal life
and continues until delivery. Therefore, the samples of meconium taken
for testing may differ in their qualitative and quantitative composition.
Another reason for the differences in the SCFAs concentration may be
the disproportions in the gut composition of the intestinal microflora of
children. It may be influenced by such factors as: latitude of the re-
search, hygienic conditions in the hospital, where the child was born, a
labor type (cesarian section / vaginal delivery). Additionally, the above
mentioned study did not take into account the impact of prenatal fac-
tors, such as maternal health, medicines used during pregnancy, diet
and lifestyle, or socioeconomic conditions.
4. Conclusions
In summary, because of the shortage of work considering the in-
fluence of the mode of delivery on the content of short-chain fatty acids
in meconium of newborns, it is advisable to conduct further experi-
ments in this field, even on a larger scale (taking into account other
factors such as the child's weight or duration of pregnancy or different
diseases). The parameters obtained during the validation process in-
dicate that the developed method using HPLC with the DAD detector is
reliable, therefore, it can be used to analyze meconium. It is expected
that through increasing number of objects and taking into consideration
other factors in multivariate statistical analysis, we will better under-
stand the role and source of the SCFAs in newborns’ gastrointestinal
tract.
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